|
Professor
|
Accepting graduate students
Research themes
Research interests
Research groups
Research summaryProfessor Peeling’s research focused on the evaluation of diagnostics to inform policy and ensure optimal uptake and sustainable adoption. Another area of her research is to explore the feasibility of using social business principles to address the inequity of access to diagnostics and other life-saving commodities and ensure the sustainability of health services delivery in resource-limited settings. Her research also involves engaging communities to understand the social, cultural and behavioural determinants in the uptake of testing and other health care services, especially in reducing the inappropriate use of antimicrobial compounds and in developing an effective epidemic/pandemic response.
BiographyRosanna Peeling is currently Professor at the Department of Medical Microbiology at the University of Manitoba and Professor/Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine and Director of the International Diagnostic Centre (IDC). Trained as a medical microbiologist, she was Research Coordinator and Head of Diagnostics Research at the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) in Geneva and Chief of the National Laboratory for Sexually Transmitted Diseases in Canada before assuming her current position. Her research focuses on defining unmet diagnostic needs and facilitating test development, evaluation and implementation in developing countries. She established the IDC to advocate the value of diagnostics, foster innovation, and accelerate access to quality-assured diagnostics to improve global health, combat the global crisis of antimicrobial resistance and control epidemics/pandemics.
Dr Peeling co-created the Social Innovation in Health Initiative (SIHI) with TDR to champion innovations in health care delivery developed by communities instead of the traditional top-down approach. SIHI has gained the support of UN agencies and donors as an important means of community engagement for countries to reach the Sustainable Development Goals. To date, SIHI has set up hubs in Africa, Asia, and south and central America to work with governments to create an enabling environment for innovation.
Dr Peeling has contributed to many WHO Guidelines, including the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD), and is currently a member of the Global Validation Advisory Committee for the Elimination of Mother-to-Child-Transmission of HIV and Syphilis, the WHO Neglected Tropical Disease Diagnostics Technical Advisory Group, the Global AMR Innovation Fund, the WHO Guideline Development Group for COVID-19 diagnostics and the WHO Access to COVID-19 Tools Accelerator (ACTA) Partnership for diagnostics. She is a member of the Africa CDC COVID-19 Pandemic Laboratory Working Group, the UK Public Health Rapid Support Team Steering Committee and the US National Academies of Science, Engineering and Medicine’s Committee on Public Health Interventions and Countermeasures for Advancing Pandemic and Seasonal Influenza Preparedness and Response.
Education
Awards
- Masters – No
- PhD - No
Research themes
- Diagnostic development
- evaluation
- implementation and access
Research interests
- Diagnostic innovation for diseases of public health importance
- Diagnostics for antimicrobial resistance
- Regulation and policy development for diagnostics
- Equitable access to life-saving health products
- Diagnostics
- Access
- Equity
- Public health
Research groups
- International Diagnostic Centre
Research summaryProfessor Peeling’s research focused on the evaluation of diagnostics to inform policy and ensure optimal uptake and sustainable adoption. Another area of her research is to explore the feasibility of using social business principles to address the inequity of access to diagnostics and other life-saving commodities and ensure the sustainability of health services delivery in resource-limited settings. Her research also involves engaging communities to understand the social, cultural and behavioural determinants in the uptake of testing and other health care services, especially in reducing the inappropriate use of antimicrobial compounds and in developing an effective epidemic/pandemic response.
BiographyRosanna Peeling is currently Professor at the Department of Medical Microbiology at the University of Manitoba and Professor/Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine and Director of the International Diagnostic Centre (IDC). Trained as a medical microbiologist, she was Research Coordinator and Head of Diagnostics Research at the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR) in Geneva and Chief of the National Laboratory for Sexually Transmitted Diseases in Canada before assuming her current position. Her research focuses on defining unmet diagnostic needs and facilitating test development, evaluation and implementation in developing countries. She established the IDC to advocate the value of diagnostics, foster innovation, and accelerate access to quality-assured diagnostics to improve global health, combat the global crisis of antimicrobial resistance and control epidemics/pandemics.
Dr Peeling co-created the Social Innovation in Health Initiative (SIHI) with TDR to champion innovations in health care delivery developed by communities instead of the traditional top-down approach. SIHI has gained the support of UN agencies and donors as an important means of community engagement for countries to reach the Sustainable Development Goals. To date, SIHI has set up hubs in Africa, Asia, and south and central America to work with governments to create an enabling environment for innovation.
Dr Peeling has contributed to many WHO Guidelines, including the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD), and is currently a member of the Global Validation Advisory Committee for the Elimination of Mother-to-Child-Transmission of HIV and Syphilis, the WHO Neglected Tropical Disease Diagnostics Technical Advisory Group, the Global AMR Innovation Fund, the WHO Guideline Development Group for COVID-19 diagnostics and the WHO Access to COVID-19 Tools Accelerator (ACTA) Partnership for diagnostics. She is a member of the Africa CDC COVID-19 Pandemic Laboratory Working Group, the UK Public Health Rapid Support Team Steering Committee and the US National Academies of Science, Engineering and Medicine’s Committee on Public Health Interventions and Countermeasures for Advancing Pandemic and Seasonal Influenza Preparedness and Response.
Education
- PhD, University of Manitoba
- MSc, University of Manitoba
- BSc, University of Toronto
Awards
- YM-YWCA Women of Distinction Award (2000)
- 5NR Award for Canadian scientists as leaders of sustainable development (2002)
- Awarded the George MacDonald Medal by the Royal Society of Tropical Medicine and Hygiene for outstanding contribution to tropical medicine (2014)
- Honorary Fellow of the Royal Society of Tropical Medicine and Hygiene (2020)